Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This spontaneous report as received from an other health professional refers to a female patient of unknown age. The patient was vaccinated with 0.65 ml ZOSTAVAX in 2008. No other co-suspects were reported. Concomitant medications included: PREDNISONE and inhaled corticosteroids (not otherwise specified). The nurse reported that she administered ZOSTAVAX to a patient that had completed a MEDROL Dosepak. The patient completed the MEDROL Dosepak a month prior to the administration of the ZOSTAVAX (administration of the ZOSTAVAX was believed to be in 2008, but nurse was not sure). The nurse reported that the patient had no adverse reaction associated with the administration of the ZOSTAVAX, but then stated that the patient has since died at age 93. On an unknown date the patient experienced death (death). No treatment information was reported. The outcome of death was reported as fatal. The date of death is not known. Nurse did not feel death was associated with ZOSTAVAX vaccination. The nurse asked about using ZOSTAVAX in a patient that is on 10 mg of Prednisone and inhaled corticosteroids. The nurse did not wish to provide additional information at the time of the call and did not wish follow up. Additional information is not expected. It has been determined that case 1210USA013797 is a duplicate of case 1210USA013349. Therefore, case 1210USA013797 is being deleted from our files and the cases consolidated into case 1210USA013349. No new information was reported.
Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166